TASK:Video presentationWEIGHTING:35%DURATION:5 - minute...

Slide 1: Title Slide
Hello, everyone. Today, I’ll be discussing Rotigotine, a drug primarily used in the treatment of Parkinson’s disease and Restless Leg Syndrome (RLS). This drug is classified as a nonergot dopamine agonist, meaning it helps to activate dopamine receptors in the brain, which are key to motor control, particularly in patients who suffer from a deficiency of dopamine. My goal today is to provide a clear understanding of how Rotigotine works, its pharmacokinetics, its clinical applications, potential side effects, and the legal and ethical considerations associated with its use.
Slide 2: Introduction
Rotigotine is administered using a transdermal patch, which is a method of delivering medication through the skin. The key advantage of this method is that it provides a steady release of the drug over a 24hour period, which is essential for diseases like Parkinson’s where constant dopamine receptor stimulation is needed to maintain motor control. Rotigotine’s transdermal system ensures that the drug is delivered at a stable rate, minimizing fluctuations in plasma levels, which helps in controlling the symptoms consistently throughout the day
Slide 3: Pharmacokinetics
"Now, let’s talk about the pharmacokinetics of Rotigotine. The term pharmacokinetics refers to how the body absorbs, distributes, metabolizes, and excretes a drug.
Absorption: After applying the patch, Rotigotine is absorbed through the skin and enters the bloodstream. This method ensures a gradual and controlled absorption, which is particularly important for managing symptoms without peaks and troughs in drug levels.
Distribution: Once in the bloodstream, about 89% of Rotigotine binds to plasma proteins. This binding helps the drug to be steadily distributed throughout the body.
Metabolism: The drug is metabolized in the liver, primarily through conjugation mechanisms, meaning it combines with glucuronic acid or sulfate for easier elimination. While the cytochrome P450 system (CYP450) plays a minor role in its metabolism, most of the breakdown happens through simpler pathways.
Excretion: Rotigotine is primarily excreted in urine, with about 71% of the drug being eliminated this way, and the remainder, around 23%, is excreted via...